Press Releases Sino Biopharmaceutical Limited

Equities

1177

KYG8167W1380

Delayed Hong Kong S.E. Other stock markets 07:40:37 03/06/2024 am IST			5-day change	1st Jan Change
2.83 ^HKD	-0.35%		0.00%	-18.16%

24/05	Sino Biopharmaceutical's Renal Cancer Combination Treatment Shows Promise in Phase III Trials	MT
23/05	Sino Biopharmaceutical Limited Announces Positive Results on Phase III Study of Benmelstobart Injection in Combination with Anlotinib Hydrochloride Capsules for First-Line Treatment of Advanced Renal Cell Carcinoma	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sino Biopharmaceutical : 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT	29/04	PU
Sino Biopharm (1177.HK) Announces 2023 Annual Results	29/03	AQ
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results	25/23/25	AQ
Sino Biopharmaceutical : 2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT	09/23/09	PU
Sino Biopharm (1177.HK) Announces 2022 Annual Results	31/23/31	AQ
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion	23/22/23	AQ
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - "LENVATINIB MESILATE CAPSULE" OBTAINS DRUG REGISTRATION CERTIFICATE	26/21/26	PU
Sino Biopharmaceutical : Donates Cash and Supplies Valued at RMB10 Million to Support Henan for Flood Relief and Preventing Epidemic	22/21/22	AQ
Sino Biopharmaceutical : 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion	24/21/24	AQ
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - "PALONOSETRON HYDROCHLORIDE INJECTION" PASSES CONSISTENCY EVALUATION	13/21/13	PU
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - "DASATINIB TABLET" PASSES CONSISTENCY EVALUATION	13/21/13	PU
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF MEDICAL OFFICER	10/21/10	PU
Sino Biopharmaceutical : NOTIFICATION OF BOARD MEETING	03/21/03	PU
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - "TIAN NENG" OBTAINS REGISTRATION CERTIFICATE OF FORMULA FOOD FOR SPECIAL MEDICAL PURPOSE	29/21/29	PU
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - "SU QIAN" OBATAINS REGISTRATION CERTIFICATE OF FORMULA FOOD FOR SPECIAL MEDICAL PURPOSE	28/21/28	PU
Sino Biopharmaceutical : NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS	22/21/22	PU
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - PENPULIMAB OBTAINED BREAKTHROUGH THERAPY DESIGNATION FROM FDA FOR THIRD-LINE TREATMENT OF METASTATIC NASOPHARYNGEAL CARCINOMA	30/21/30	PU
Sino Biopharmaceutical : 2020 Net Profit Grows to RMB2.77 Billion amid Adversity	23/21/23	AQ
Sino Biopharmaceutical : VOLUNTARY ANNOUNCEMENT - ACQUISTION OF SOFTHALE	23/21/23	PU
Sino Biopharmaceutical : ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER, 2020	23/21/23	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sino Biopharmaceutical Limited

Equities

1177

KYG8167W1380

Press Releases

Filters